151 related articles for article (PubMed ID: 30547386)
41. Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS
Findley A; Middlehurst JM; Howse CA; Clifford MJ; Neill W; Tatlock S; Chen WH; Bracher MG; Patel DS
J Patient Rep Outcomes; 2023 Apr; 7(1):39. PubMed ID: 37079188
[TBL] [Abstract][Full Text] [Related]
42. Gastric electrical stimulation: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(16):1-79. PubMed ID: 23074486
[TBL] [Abstract][Full Text] [Related]
43. Nausea and vomiting in gastroparesis: similarities and differences in idiopathic and diabetic gastroparesis.
Parkman HP; Hallinan EK; Hasler WL; Farrugia G; Koch KL; Calles J; Snape WJ; Abell TL; Sarosiek I; McCallum RW; Nguyen L; Pasricha PJ; Clarke J; Miriel L; Lee L; Tonascia J; Hamilton F;
Neurogastroenterol Motil; 2016 Dec; 28(12):1902-1914. PubMed ID: 27350152
[TBL] [Abstract][Full Text] [Related]
44. Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sjögren's syndrome dry eye disease.
Sloesen B; Young A; Forde K; Hodson N; Bentley S; Walsh O; Naujoks C; O'Brien P; Sharma G
J Patient Rep Outcomes; 2023 Jul; 7(1):64. PubMed ID: 37405617
[TBL] [Abstract][Full Text] [Related]
45. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M
Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235
[TBL] [Abstract][Full Text] [Related]
46. Different faces of gastroparesis.
Bielefeldt K; Raza N; Zickmund SL
World J Gastroenterol; 2009 Dec; 15(48):6052-60. PubMed ID: 20027677
[TBL] [Abstract][Full Text] [Related]
47. Effectiveness of gastric electrical stimulation in gastroparesis: Results from a large prospectively collected database of national gastroparesis registries.
Abell TL; Yamada G; McCallum RW; Van Natta ML; Tonascia J; Parkman HP; Koch KL; Sarosiek I; Farrugia G; Grover M; Hasler W; Nguyen L; Snape W; Kuo B; Shulman R; Hamilton FA; Pasricha PJ
Neurogastroenterol Motil; 2019 Dec; 31(12):e13714. PubMed ID: 31584238
[TBL] [Abstract][Full Text] [Related]
48. Electroacupuncture combined with mosapride alleviates symptoms in diabetic patients with gastroparesis.
Pan W; Wang Z; Tian F; Yan M; Lu Y
Exp Ther Med; 2017 Apr; 13(4):1637-1643. PubMed ID: 28413522
[TBL] [Abstract][Full Text] [Related]
49. Gastroparesis and gastroparesis-like syndrome: response to therapy and its predictors.
Anaparthy R; Pehlivanov N; Grady J; Yimei H; Pasricha PJ
Dig Dis Sci; 2009 May; 54(5):1003-10. PubMed ID: 19277867
[TBL] [Abstract][Full Text] [Related]
50. Proof of concept: short-term non-invasive cervical vagus nerve stimulation in patients with drug-refractory gastroparesis.
Paulon E; Nastou D; Jaboli F; Marin J; Liebler E; Epstein O
Frontline Gastroenterol; 2017 Oct; 8(4):325-330. PubMed ID: 29067158
[TBL] [Abstract][Full Text] [Related]
51. Open-label pilot study: Non-invasive vagal nerve stimulation improves symptoms and gastric emptying in patients with idiopathic gastroparesis.
Gottfried-Blackmore A; Adler EP; Fernandez-Becker N; Clarke J; Habtezion A; Nguyen L
Neurogastroenterol Motil; 2020 Apr; 32(4):e13769. PubMed ID: 31802596
[TBL] [Abstract][Full Text] [Related]
52. Effect of
Mahjoub F; Salari R; Yousefi M; Mohebbi M; Saki A; Rezayat KA
Electron Physician; 2018 Jul; 10(7):6997-7007. PubMed ID: 30128090
[TBL] [Abstract][Full Text] [Related]
53. The Short-Term Effects and Tolerability of Low-Viscosity Soluble Fibre on Gastroparesis Patients: A Pilot Clinical Intervention Study.
Suresh H; Zhou J; Ho V
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959850
[TBL] [Abstract][Full Text] [Related]
54. A cross-sectional study describing peripheral neuropathy in patients with symptoms of gastroparesis: associations with etiology, gastrointestinal symptoms, and gastric emptying.
Moors VJ; Graveran KD; Shahsavari D; Parkman HP
BMC Gastroenterol; 2022 Jun; 22(1):315. PubMed ID: 35761166
[TBL] [Abstract][Full Text] [Related]
55. Pilot Double-Blind Randomised Controlled Trial: Effects of Jejunal Nutrition on Postprandial Distress in Diabetic Gastropathy (J4G Trial).
Carneiro L; White J; Parker H; Hoad C; Tucker E; Marciani L; Gowland P; Gazis T; Walker M; Fox M
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405934
[TBL] [Abstract][Full Text] [Related]
56. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity.
Parkman HP; Yates K; Hasler WL; Nguyen L; Pasricha PJ; Snape WJ; Farrugia G; Koch KL; Abell TL; McCallum RW; Lee L; Unalp-Arida A; Tonascia J; Hamilton F;
Gastroenterology; 2011 Jan; 140(1):101-15. PubMed ID: 20965184
[TBL] [Abstract][Full Text] [Related]
57. Symptoms Suggestive of Gastroparesis in a Community-Based Cohort of European Americans and African Americans with Type 2 Diabetes Mellitus.
Brown LK; Xu J; Freedman BI; Hsu FC; Bowden DW; Koch KL
Dig Dis Sci; 2020 Aug; 65(8):2321-2330. PubMed ID: 31820181
[TBL] [Abstract][Full Text] [Related]
58. Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis.
McCallum RW; Lembo A; Esfandyari T; Bhandari BR; Ejskjaer N; Cosentino C; Helton N; Mondou E; Quinn J; Rousseau F;
Neurogastroenterol Motil; 2013 Nov; 25(11):e705-17. PubMed ID: 23848826
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of
Singh A; Kant R; Raina R; Dhingra V; Nema R; Bairwa MC; Kanwar V; Mukherjee RLS; Mirza AA; Agarwal M
Indian J Endocrinol Metab; 2024; 28(1):35-42. PubMed ID: 38533281
[TBL] [Abstract][Full Text] [Related]
60. The Vulvodynia Experience Questionnaire: Qualitative Development of a New Patient-Reported Outcome Measure for Vulvodynia.
Goldstein AT; Diez PMQ; Kapanadze S; Cala ML; Evans CJ; Whyte JL; Christoph A
J Sex Med; 2020 Oct; 17(10):2055-2066. PubMed ID: 32900670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
